Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older — United States, 2015 Academic Article uri icon


MeSH Major

  • Immunization Schedule
  • Influenza Vaccines
  • Pneumococcal Vaccines
  • Practice Guidelines as Topic


  • In October 2014, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2015. This schedule provides a summary of ACIP recommendations for the use of vaccines routinely recommended for adults aged 19 years or older in two figures, footnotes for each vaccine, and a table that describes primary contraindications and precautions for commonly used vaccines for adults. Changes in the 2015 adult immunization schedule from the 2014 schedule included the August 2014 recommendation for routine administration of the 13-valent pneumococcal conjugate vaccine (PCV13) in series with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all adults aged 65 years or older, the August 2014 revision on contraindications and precautions for the live attenuated influenza vaccine (LAIV), and the October 2014 approval by the Food and Drug Administration to expand the approved age for use of recombinant influenza vaccine (RIV). These revisions were also reviewed and approved by the American College of Physicians, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and American College of Nurse-Midwives.


publication date

  • January 2015



  • Academic Article



  • eng

PubMed Central ID

  • PMC4584856

PubMed ID

  • 25654609

Additional Document Info

start page

  • 91

end page

  • 2


  • 64


  • 4